Diethyl P-((4-methoxyphenyl)methyl)phosphonate

HCID 4063826

노트 반응

부분 구조 검색 유사 구조 찾기

기본 정보

CAS: 1145-93-3
표준 SMILES: CCOP(=O)(Cc1ccc(OC)cc1)OCC
InChIKey: NKARVHNAACNYGE-UHFFFAOYSA-N
분자식: C12H19O4P
평균 분자량: 258.25 g/mol
단동위원소 질량: 258.10209572

이름 및 식별자

우선 이름: Diethyl P-((4-methoxyphenyl)methyl)phosphonate
IUPAC: 1-(diethoxyphosphorylmethyl)-4-methoxybenzene
영어명: Diethyl 4-methoxybenzylphosphonate
분자식: C12H19O4P
분자량: 258.25

이름 및 동의어

1145-93-3DTXSID101249159Diethyl P-((4-methoxyphenyl)methyl)phosphonateDiethyl P-[(4-methoxyphenyl)methyl]phosphonateRefChem:1083510DTXCID301679980Diethyl 4-methoxybenzylphosphonateDiethyl (4-Methoxybenzyl)phosphonate1-(diethoxyphosphorylmethyl)-4-methoxybenzeneMFCD00015662Diethyl(4-methoxybenzyl)phosphonate1-(diethoxyphosphorylmethyl)-4-methoxy-benzene

이름 더 보기

Diethyl anisylphosphonateDiethyl 4-methoxybenzylphosphoteDiethyl(4-Methoxybenzyl)phosphonate>Diethyl(4-methoxybenzyl)phosphonate, 98 %(p-Methoxybenzyl)phosphonic acid diethyl ester

Phosphonic acid, P-[(4-methoxyphenyl)methyl]-, diethyl esterdiethyl [(4-methoxyphenyl)methyl]phosphonate4-(Diethylphosphonomethyl)anisoleethoxy-ethylperoxy-[(4-methoxyphenyl)methyl]phosphaneDiethyl 4-methoxybenzylphosphonate, >=98%Phosphonic acid, [(4-methoxyphenyl)methyl]-, diethyl ester4-methoxybenzylphosphonic acid diethyl esterFT-0618929

데이터베이스 식별자

CAS: 1145-93-3
PubChem CID: 4063826
DTXSID: DTXSID101249159
EC Number: 214-548-5
Nikkaji: J93.740A

물성

구조 계산 물성

XLogP: 1.7
극성 표면적: 44.8 Å²
수소 결합 공여자 수: 0
수소 결합 수용자 수: 4
회전 가능 결합 수: 7
무거운 원자 수: 17
형식 전하: 0
복잡도: 239

물리화학적 성질

끓는 점: 155 °C0.5 · 155 °C0.5 mm Hg(lit.)
밀도: 1.5 g/mL · 1.5 g/mL at 25 °C(lit.)
굴절률: 20 · n20/D 1.504(lit.)
인화점: 230 °F · >230 °F
저장 조건: Store at room temperature
물리적 상태: 투명한 액체
색상: 무색~연황색
수용성: 물과 섞이지 않습니다.
BRN: 2125148 · 2125148

안전 및 규제

안전 데이터

wgk: 3
HS 번호: 2931499090
risk_code: 36/37/38
hazard_code: Xi
safety_code: 26-36/37/39

화학 및 산업

응용 분야 · 1건

용도Diethyl 4-methoxybenzylphosphonate is used in synthesis of C-aryl glycosides. It acts as a reactant for synthesis of γ -Monofluorinated goniothalamin analogs via ring-opening hydrofluorination, stilbenoid derivatives with neuroprotective activity, resveratrol-chroman hybrids with antioxidant activity, Oligostilbenoids using regioselective cyclodehydration and arylation.